Your browser doesn't support javascript.
loading
Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil
Bhering, Marcela; Dalcolmo, Margareth; Sarubbi Júnior, Vicente; Kritski, Afrânio.
  • Bhering, Marcela; Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sérgio Arouca. Rio de Janeiro. BR
  • Dalcolmo, Margareth; Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sérgio Arouca. Rio de Janeiro. BR
  • Sarubbi Júnior, Vicente; Universidade Estatual de Mato Grosso do Sul. Faculdade de Medicina. Campo Grande. BR
  • Kritski, Afrânio; Universidade Federal do Rio de Janeiro. Faculdade de Medicina. Programa Acadêmico de Tuberculose. Rio de Janeiro. BR
Rev. saúde pública (Online) ; 56: 1-11, 2022. tab, graf
Article in English | LILACS, BBO | ID: biblio-1390006
ABSTRACT
ABSTRACT OBJECTIVE To understand patients' narratives about the barriers they faced in the diagnosis and treatment of multidrug-resistant tuberculosis, and their consequences in Rio de Janeiro State, Brazil. METHODS This is a qualitative cross-sectional study with non-probabilistic sampling. A theoretical saturation criterion was considered for composing the number of interviewees. Semi-structured interviews were conducted from August to December 2019 with 31 patients undergoing treatment for multidrug-resistant tuberculosis at an outpatient referral center in Rio de Janeiro. Data were transcribed and processed with the aid of the NVIVO software. Interviews were evaluated by content analysis, and their themes, cross-referenced with participants' characterization data. RESULTS Our main findings were a) participants show a high proportion of primary drug resistance, b) patients experience delays in the diagnosis and effective treatment of multidrug-resistant tuberculosis ; c) healthcare providers fail to value or seek the diagnosis of drug-resistant tuberculosis, thus beginning the inadequate treatment for drug-susceptible tuberculosis, d) primary health units show low report rates of active case-finding and contact monitoring, and e) patients show poor knowledge about the disease. CONCLUSIONS We need to improve referral systems, and access to the diagnosis and effective treatment of multidrug-resistant tuberculosis; conduct an active investigation of contacts; intensify the training of healthcare providers, in collaboration with medical and nursing schools, in both public and private systems; and promote campaigns to educate the population on tuberculosis signs and symptoms.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Tuberculosis / Tuberculosis, Multidrug-Resistant Type of study: Diagnostic study / Observational study / Prevalence study / Qualitative research / Risk factors Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Rev. saúde pública (Online) Journal subject: Sa£de P£blica Year: 2022 Type: Article Affiliation country: Brazil Institution/Affiliation country: Fundação Oswaldo Cruz/BR / Universidade Estatual de Mato Grosso do Sul/BR / Universidade Federal do Rio de Janeiro/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Tuberculosis / Tuberculosis, Multidrug-Resistant Type of study: Diagnostic study / Observational study / Prevalence study / Qualitative research / Risk factors Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: Rev. saúde pública (Online) Journal subject: Sa£de P£blica Year: 2022 Type: Article Affiliation country: Brazil Institution/Affiliation country: Fundação Oswaldo Cruz/BR / Universidade Estatual de Mato Grosso do Sul/BR / Universidade Federal do Rio de Janeiro/BR